Advertisement

Influence of anti-inflammatory drugs on PHA-stimulated lymphocyte proliferation with variable numbers of macrophages

  • H. Mullink
  • Mary Von Blomberg-Van Der Flier
  • J. Zaagsma
  • J. Oort
Part of the Inflammation: Mechanisms and Treatment book series (FTIN, volume 4)

Abstract

Together with macrophages, lymphocytes are known to be the predominant cell type in chronic inflammatory infiltrates. In order to establish the influence of anti-inflammatory drugs (AID) on the function of these cells, we studied the in vitro effect of AID in lymphocyte transformation tests (LTT) with phytohaemagglutinin (PHA). This mitogen is known to induce proliferation of T-lymphocytes nonspecifically.

Keywords

Acetyl Salicylic Acid Lymphocyte Proliferation Mefenamic Acid Predominant Cell Type Lymphocyte Transformation Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Opelz; G., Terasaki, P. and Herata, A. A. (1973). Lancet, 2, 478PubMedCrossRefGoogle Scholar
  2. 2.
    Forbes, I. J. and Smith, J. L. (1967). Lancet, 2, 334PubMedCrossRefGoogle Scholar
  3. 3.
    Ambrose, C. T. (1966). J. Exp. Med., 124, 461PubMedCrossRefGoogle Scholar
  4. 4.
    Winchurch, R. A., Foschi G. V. and Walz, D. T. (1974). J. Retículoendothel Soc., 15, 112PubMedGoogle Scholar
  5. 5.
    Park, S. K. and Brody, J. T. (1971). Natl. New Biol., 233, 181Google Scholar
  6. 6.
    Smith, J. L. and Forbes, I. J. (1967). Nature (London), 215, 538CrossRefGoogle Scholar
  7. 7.
    Packman, M., Esterley, N.B. and Peterson, R.D. A. (1971). J. Clin. Invest, 50, 226CrossRefGoogle Scholar
  8. 8.
    Gabourel, J.D., Davies, G. H. and Rittenberg, M. B. (1977). Clin. Immunol. Immuno-pathol., 7, 53CrossRefGoogle Scholar
  9. 9.
    Muscoplat, C. C., Rakich, P. M., Thoen, C. O. and Johnson, D. W. (1978). Infect. Immun., 627Google Scholar
  10. 10.
    Goodwin, J.S., Bankhurst, A.D., Murphy, S.A., Selinger, D. S., Mussner R.P. and Williams, R. C. (1978). J. Clin. Lab. Immunol, 1, 197PubMedGoogle Scholar
  11. 11.
    Sohnle, P. G. and Collins-Lech, C. (1979). Clin. Immunol. Immunopathol, 13, 47PubMedCrossRefGoogle Scholar
  12. 12.
    Barasoain, J., Rojo, J. M. and Portolés, A. (1979). Immunopharmacology, 2, 83PubMedCrossRefGoogle Scholar
  13. 13.
    Rosenstreich, D. L. and Mizel, S. B. (1978). Immunol. Rev., 40, 102PubMedCrossRefGoogle Scholar
  14. 14.
    Mookerjee, B. K. (1977). Transplantation, 23, 22PubMedCrossRefGoogle Scholar
  15. 15.
    de Vries, J.E., Cavilles, A.P., Bont, W.S. and Mendelsohn, J. (1979). J. Immunol., 1099Google Scholar
  16. 16.
    Hojo, K. and Hiramine, C. (1979). Scand. J. Immunol., 9, 381PubMedCrossRefGoogle Scholar
  17. 17.
    Rinehart, J. J., Orser, M. and Kaplan, M. E. (1979). Cell. Immunol., 44, 131PubMedCrossRefGoogle Scholar
  18. 18.
    Brondz, B.D., Khachikyan, E. Y. and Karaulov, A. V. (1979). Bull. Exp. Biol. Med., 87, 329CrossRefGoogle Scholar
  19. 19.
    Goodwin, J. S., Bankhurst, A.D. and Messner, R. P. (1977). J. Exp. Med., 146, 1719PubMedCrossRefGoogle Scholar
  20. 20.
    Lipsky, P. E. and Rosenthal, A. S. (1976). J. Immunol., 187, 1594Google Scholar
  21. 21.
    Lause, D. B. (1979). J. Reticuloendothel. Soc., 26, 775PubMedGoogle Scholar
  22. 22.
    Ansfield, M.J., Kaltreider, H.B., Caldwell, J. L. and Herskowitz, F.N. (1979). J. Immunol., 122, 542PubMedGoogle Scholar
  23. 23.
    Humes, J.L., Bonney, R. J., Peius, L., Dahlgren, M. E., Sadowski, S. J., Kuehl, F. A. and Davies, P. (1977). Nature (London), 269, 149CrossRefGoogle Scholar
  24. 24.
    Kurland, J.J. and Bockman, R. (1978).J. Exp. Med., 147, 952PubMedCrossRefGoogle Scholar
  25. 25.
    Bray, M. A. and Gordon, D. (1978). Br. J. Pharmacol., 63, 635PubMedGoogle Scholar
  26. 26.
    Gordon, D., Bray, M. and Morley, J. (1976). Nature (London), 262, 401CrossRefGoogle Scholar
  27. 27.
    Muscoplat, C.C., Klausner, D.J., Brunner, C.J., Sloane, E.D. and Johnson, D.W. (1979). Infect. Immun., 26, 311PubMedGoogle Scholar
  28. 28.
    von Blomber, M. and Scheper, R. J. (1980). Immunology, 39, 291Google Scholar
  29. 29.
    Mullink, H., von Blomberg, M., Wilders, M. M., Drexhage, H. A. and Alons, C. L. (1979). J. Immunol. Meth., 29, 133CrossRefGoogle Scholar
  30. 30.
    Stadecker, M. J., Bishop, G. and Wortis, H. H. (1973). J. Immunol., 111, 1834PubMedGoogle Scholar
  31. 31.
    Seeman, P. (1972). Pharmacol. Rev., 24, 583PubMedGoogle Scholar
  32. 32.
    Haynes, B. F. and Fauci, A. S. (1979). Cell. Immunol., 44, 157PubMedCrossRefGoogle Scholar
  33. 33.
    Rosenberg, J. C. and Lysz, K. (1978). Transplantation, 25, 115PubMedCrossRefGoogle Scholar
  34. 34.
    Claman, H. N. (1972). New Engl. J. Med., 388 Google Scholar
  35. 35.
    Muraki Krishna Rao, K., Schwartz, S. A. and Good, R. A. (1979). Cell. Immunol., 48, 155CrossRefGoogle Scholar
  36. 36.
    Goodwin, J. E. and Messner, R. P. (1979). J. Clin. Invest., 64, 434PubMedCrossRefGoogle Scholar
  37. 37.
    Gordon, D., Henderson, D.C. and Westwick, J. (1979). Br.J. Pharmacol., 67, 17PubMedGoogle Scholar
  38. 38.
    Bonta, I. L. (1977). Agents Actions Suppl., 121,Google Scholar
  39. 39.
    Morley, J. (1974). Prostaglandins, 8, 315PubMedCrossRefGoogle Scholar
  40. 40.
    Goodwin, J. S. and Webb, D. R. (1980). Clin. Immunol. Immunopathol., 15, 106PubMedCrossRefGoogle Scholar
  41. 41.
    Oort, J. and Mullink, H. (1974). Proceedings ofthe 4th International Symposium of Medicinal Chemistry, Maas, J. (ed.), pp. 1–15Google Scholar
  42. 42.
    Flower, R. J. (1974). Pharmacol. Rev., 26, 33PubMedGoogle Scholar
  43. 43.
    Moneada, S., Needleman, P., Bunting, S. and Vane, J. R. (1976). Prostaglandins, 12, 323CrossRefGoogle Scholar
  44. 44.
    Peius, L. M. and Strausser, H. R. (1976). Int. J. Cancer, 18, 653CrossRefGoogle Scholar
  45. 45.
    Lynch, N. R. and Salomon, J. (1979). J. Natl. Cancer. Inst., 62, 117PubMedGoogle Scholar
  46. 46.
    Goodwin, J. S., Messner, R. P. and Bankhurst, R. P. (1977). N. Engl. J. Med., 297, 263CrossRefGoogle Scholar
  47. 47.
    Goodwin, J.S., DeHoratius, R., Israel, H., Peake, G.T. and Messner, R. P. (1979). Ann. Int. Med., 90, 169PubMedGoogle Scholar
  48. 48.
    Ellner, J. J. and Spagnuolo, P. J. (1979). J. Immunol., 123, 2689PubMedGoogle Scholar
  49. 49.
    Flower, R. J., Cheung, H. S. and Cushman, D. W. (1973). Prostaglandins, 4, 325PubMedCrossRefGoogle Scholar
  50. 50.
    Hawkins, D., Pinckard, R. N., Crawford, I. P. and Farr, R. S. (1969). J. Clin. Invest., 48, 536PubMedCrossRefGoogle Scholar
  51. 51.
    GarciaLeme, J., Ramos de Oliveira, J. C., Sudo, L. S. and Verissimo de Mello, S.B. (1978). Br. J. Exp. Pathol., 59, 345Google Scholar
  52. 52.
    Roux, F., Treich, I., Brun, C., Desrize, B. and Fournier, E. (1979). Biochem. Pharmacol., 28, 2419PubMedCrossRefGoogle Scholar
  53. 53.
    Stites, D. P., Brecher, G., Schmidt, L. and Berger, F. (1979). Immunopharmacology, 2, 39PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1980

Authors and Affiliations

  • H. Mullink
    • 1
  • Mary Von Blomberg-Van Der Flier
    • 1
  • J. Zaagsma
    • 1
  • J. Oort
    • 1
  1. 1.Netherlands

Personalised recommendations